Chapter 5 Carboxylic Acids and Esters
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Methyl Ethyl Ketone (2-Butanone)
Methyl Ethyl Ketone (2-Butanone) 78-93-3 Hazard Summary Methyl ethyl ketone is used as a solvent. Acute (short-term) inhalation exposure to methyl ethyl ketone in humans results in irritation to the eyes, nose, and throat. Limited information is available on the chronic (long-term) effects of methyl ethyl ketone in humans. Chronic inhalation studies in animals have reported slight neurological, liver, kidney, and respiratory effects. No information is available on the developmental, reproductive, or carcinogenic effects of methyl ethyl ketone in humans. Developmental effects, including decreased fetal weight and fetal malformations, have been reported in mice and rats exposed to methyl ethyl ketone via inhalation and ingestion. EPA has classified methyl ethyl ketone as a Group D, not classifiable as to human carcinogenicity. Please Note: The main sources of information for this fact sheet are EPA's Health Effects Assessment for Methyl Ethyl Ketone (1) and EPA's Integrated Risk Information System (IRIS) (6), which contains information on inhalation chronic toxicity of methyl ethyl ketone and the RfC and oral chronic toxicity and the RfD. Uses The primary use of methyl ethyl ketone is as a solvent in processes involving gums, resins, cellulose acetate, and cellulose nitrate. (1) Methyl ethyl ketone is also used in the synthetic rubber industry, in the production of paraffin wax, and in household products such as lacquer and varnishes, paint remover, and glues. (1) Sources and Potential Exposure Methyl ethyl ketone has been detected in both indoor and outdoor air. Methyl ethyl ketone can be produced in outdoor air by the photooxidation of certain air pollutants, such as butane and other hydrocarbons. -
Ebook for A2.2 Chemistry
eBook for A2.2 Chemistry Chemistry in Medicine 5.11. [Pages 94 – 107 of A2.2 eBook] • You will be expected to be able to explain the use of indigestion remedies to cure excess hydrochloric acid in the stomach stating the types of compounds used and writing equations for their reactions. • You will be expected to be able to use a back titration to determine the percentage of an active ingredient in an indigestion remedy and perform various calculations on the titration. • You will be expected to be able to explain how to deal with variations in the pH values of skin, explain the role of fatty acids in skin pH and explain the use of corrosive chemicals in removing warts. • You will be expected to be able to recall and explain the use of silver nitrate in the treatment of eye diseases. • You will be expected to be able to explain the action of anticancer drugs, for example cisplatin in preventing DNA replication in cancer cells and how varying the structure of cisplatin affects the efficiency of anticancer activity • You will be expected to be able to carry out titrations to determine the concentration of aspirin in solution and carry out associated calculations. • You will be expected to be able to recall the synthesis of aspirin from salicylic acid and ethanoic anhydride and compare it with the use of ethanoic acid and ethanoyl chloride and explain why the sodium salt of aspirin is often used rather than aspirin. • You will be expected to be able to explain the use of GLC linked to MS to identify drugs and to determine their purity. -
Methyl Isopropyl Ketone Safety Data Sheet According to Federal Register / Vol
Methyl isopropyl ketone Safety Data Sheet according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations Date of issue: 05/25/2015 Version: 1.0 SECTION 1: Identification 1.1. Identification Product form : Substance Substance name : Methyl isopropyl ketone CAS-No. : 563-80-4 Product code : (US) W1814 Formula : C5H10O Synonyms : 3-Methylbutane-2-one / Isopropyl methyl ketone / Methyl-2-butanone, 3- / 2-Acetylpropane / 3- Methylbutanone-2 / 3-Methylbutanone / 3-Methylbutan-2-one / 3-Methyl-2-butanone / 2- Butanone, 3-methyl- / Butan-2-one, 3-methyl- 1.2. Recommended use and restrictions on use No additional information available 1.3. S upplie r Synerzine 5340 Hwy 42 S Ellenwood, Georgia 30294 - USA T 404-524-6744 - F 404-577-1651 [email protected] - www.synerzine.com 1.4. Emergency telephone number Emergency number : Infotrac 1-800-535-5053 (Contract# 102471) Dial +1-352-323-3500 when outside the US SECTION 2: Hazard(s) identification 2.1. Classification of the substance or mi xt ure GHS -US classification Flammable liquids Category H225 Highly flammable liquid and vapour 2 Specific target organ toxicity H336 May cause drowsiness or dizziness (single exposure) Category 3 Hazardous to the aquatic H402 Harmful to aquatic life environment - Acute Hazard Category 3 Full text of H statements : see section 16 2.2. GHS Label elements, including precautionary statements GHS-US labeling Hazard pictograms (GHS-US) : Signal word (GHS-US) : Danger Hazard statements (GHS-US) : H225 - Highly flammable liquid and vapour H336 - May cause drowsiness or dizziness H402 - Harmful to aquatic life Precautionary statements (GHS-US) : P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. -
Effect of Enzymes on Strawberry Volatiles During Storage, at Different Ripeness
Effect of Enzymes on Strawberry Volatiles During Storage, at Different Ripeness Level, in Different Cultivars and During Eating Thesis Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in the Graduate School of The Ohio State University By Gulsah Ozcan Graduate Program in Food Science and Technology The Ohio State University 2010 Thesis Committee: Sheryl Ann Barringer, Adviser W. James Harper John Litchfield 1 Copyright by Gülşah Özcan 2010 ii ABSTRACT Strawberry samples with enzyme activity and without enzyme activity (stannous chloride added) were measured for real time formation of lipoxygenase (LOX) derived aroma compounds after 5 min pureeing using selected ion flow tube mass spectrometry (SIFT-MS). The concentration of (Z)-3-hexenal and (E)-2-hexenal increased immediately after blending and gradually decreased over time while hexanal concentration increased for at least 5 min in ground strawberries. The formation of hexanal was slower than the formation of (Z)-3-hexenal and (E)-2-hexenal in the headspace of pureed strawberries. The concentration of LOX aldehydes and esters significantly increased during refrigerated storage. Damaging strawberries increased the concentration of LOX aldehydes but did not significantly affect the concentration of esters. The concentrations of many of the esters were strongly correlated to their corresponded acids and/or aldehydes. The concentration of LOX generated aldehydes decreased during ripening, while fruity esters increased. Different varieties had different aroma profiles and esters were the greatest percentage of the volatiles. The aroma release of some of the LOX derived aldehydes in the mouthspace in whole strawberries compared to chopped strawberries showed that these volatiles are formed in the mouth during chewing. -
PRODUCT INFORMATION Mefenamic Acid Item No
PRODUCT INFORMATION Mefenamic Acid Item No. 23650 CAS Registry No.: 61-68-7 OH Formal Name: 2-[(2,3-dimethylphenyl)amino]-benzoic acid O Synonyms: C.I. 473, CN 35355, NSC 94437 H C H NO MF: 15 15 2 N FW: 241.3 Purity: ≥98% Supplied as: A solid Storage: 4°C Stability: ≥1 year Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis. Laboratory Procedures Mefenamic acid is supplied as a solid. A stock solution may be made by dissolving the mefenamic acid in the solvent of choice, which should be purged with an inert gas. Mefenamic acid is slightly soluble in DMSO and methanol. Description Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) and a COX-2 inhibitor.1 It binds to COX-2 (Kd = 4 nM) and inhibits COX-2-dependent oxygenation of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in vitro (Ki = 10 µM). Mefenamic acid (30 mg/kg) reduces acetic acid-induced writhing in rats.2 It inhibits increases in skin thickness in a mouse model of delayed-type hypersensitivity induced by dinitrochlorobenzene (DNBC).2 Mefenamic acid also reduces the antibody response to sheep red blood cells in mice. References 1. Prusakiewicz, J.J., Duggan, K.C., Rouzer, C.A., et al. Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid. Biochemistry 48(31), 7353-7355 (2009). 2. Roszkowski, A.P., Rooks, W.H., Tomolonis, A.J., et al. Anti-inflammatory and analgetic properties of d-2-(6’-methoxy-2’-naphthyl)-propionic acid (naproxen). -
Draft SANCO 10387 V.12 CAS No Endringer Draft Vs. Dir 2004/4/EC Endringer Draft CAC/RCP 36 - 1987 Dir 2004/4/EC Vs
Draft SANCO 10387 v.12 CAS No Endringer draft vs. Dir 2004/4/EC Endringer draft CAC/RCP 36 - 1987 dir 2004/4/EC vs. CAC/RCP 36 - 1987 Acetic acid (ethanoic acid; vinegar acid; methane carboxylic 64-19-7 Redigert Acetic acid Acetic acid acid) Acetic anhydride (ethanoic anhydride) 108-24-7 Acetic anhydride (ethanoic anhydride Acetic anhydride (ethanoic anhydride Acid oils and fatty acid distillates — from vegetable oils and fats --- Acid oils and fatty acid distillates — from vegetable oils and fats Endret Acid oils and fatty acid distillates - from animal, marine and and/or mixtures thereof and animal and marine fats and oils and/or mixtures thereof and animal and marine fats and oils vegetable fats and oils Acetone (dimethylketone; 2-propanone) 67-64-1 Acetone (dimethylketone; 2-propanone) Acetone (dimethylketone; 2-propanone) Ammonium hydroxide (ammonium hydrate; ammonia solution; 1336-21-6 Ammonium hydroxide (ammonium hydrate; ammonia solution; Ammonium hydroxide (ammonium hydrate; ammonia solution; aqua ammonia) aqua ammonia) aqua ammonia) Ammonium polyphosphate 68333-79-9 Ammonium polyphosphate Ammonium polyphosphate and 10124-31- 9 Animal, marine and vegetable and hydrogenated oils and fats --- Endret Animal, marine and vegetable and hydrogenated oils and fats Animal, marine and vegetable and hydrogenated oils and fats according to the MEPC.2/Circ. of the IMO. (other than cashew shell nut and crude tall oil) according to the MEPC of the IMO. Benzyl alcohol (pharmaceutical and reagent grades only) 100-51-6 Redigert Benzyl alcohol (pharmaceutical -
Derivatives of Carboxylic Acid
Derivatives of Carboxylic Acid acid chloride carboxylate nitrile amide acid anhydride ester Nomenclature of Acid Halides IUPAC: alkanoic acid → alkanoyl halide Common: alkanic acid → alkanyl halide I: 3-aminopropanoyl chloride I: 4-nitropentanoyl chloride c: b-aminopropionyl chloride c: g-nitrovaleryl chloride I: hexanedioyl chloride c: adipoyl chloride Rings: (IUPAC only): ringcarbonyl halide I: benzenecarbonyl bromide I: 3-cylcopentenecarbonyl chloride c: benzoyl bromide Nomenclature of Acid Anhydrides Acid anhydrides are prepared by dehydrating carboxylic acids acetic anhydride ethanoic acid ethanoic anhydride I: benzenecarboxylic anhydride I: butanedioic acid I: butanedioic anhydride c: benzoic andhydride c: succinic acid c: succinic anhydride Some unsymmetrical anhydrides I: ethanoic methanoic I: benzoic methanoic anhydride anhydride I: cis-butenedioic c: benzoic formic anhydride anhydride c: acetic formic anhydride Nomenclature of Esters Esters occur when carboxylic acids react with alcohols I: phenyl methanoate I: t-butyl benzenecarboxylate I: methyl ethanoate c: phenyl formate c: methyl acetate c: t-butyl benzoate I: isobutyl I: cyclobutyl 2- I: dimethyl ethanedioate cyclobutanecarboxylate methylpropanoate c: cyclobutyl a- c: dimethyl oxalate c: none methylpropionate Cyclic Esters Reaction of -OH and -COOH on same molecule produces a cyclic ester, lactone. To name, add word lactone to the IUPAC acid name or replace the -ic acid of common name with -olactone. 4-hydroxy-2-methylpentanoic acid lactone -methyl- -valerolactone Amides Product of the reaction of a carboxylic acid and ammonia or an amine. Not basic because the lone pair on nitrogen is delocalized by resonance. Classes of Amides 1 amide has one C-N bond (two N-H). 2 amide or N-substituted amide has two C-N bonds (one N-H). -
N-Acyl-Dopamines: Novel Synthetic CB1 Cannabinoid-Receptor Ligands
Biochem. J. (2000) 351, 817–824 (Printed in Great Britain) 817 N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Tiziana BISOGNO*, Dominique MELCK*, Mikhail Yu. BOBROV†, Natalia M. GRETSKAYA†, Vladimir V. BEZUGLOV†, Luciano DE PETROCELLIS‡ and Vincenzo DI MARZO*1 *Istituto per la Chimica di Molecole di Interesse Biologico, C.N.R., Via Toiano 6, 80072 Arco Felice, Napoli, Italy, †Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, R. A. S., 16/10 Miklukho-Maklaya Str., 117871 Moscow GSP7, Russia, and ‡Istituto di Cibernetica, C.N.R., Via Toiano 6, 80072 Arco Felice, Napoli, Italy We reported previously that synthetic amides of polyunsaturated selectivity for the anandamide transporter over FAAH. AA-DA fatty acids with bioactive amines can result in substances that (0.1–10 µM) did not displace D1 and D2 dopamine-receptor interact with proteins of the endogenous cannabinoid system high-affinity ligands from rat brain membranes, thus suggesting (ECS). Here we synthesized a series of N-acyl-dopamines that this compound has little affinity for these receptors. AA-DA (NADAs) and studied their effects on the anandamide membrane was more potent and efficacious than anandamide as a CB" transporter, the anandamide amidohydrolase (fatty acid amide agonist, as assessed by measuring the stimulatory effect on intra- hydrolase, FAAH) and the two cannabinoid receptor subtypes, cellular Ca#+ mobilization in undifferentiated N18TG2 neuro- CB" and CB#. NADAs competitively inhibited FAAH from blastoma cells. This effect of AA-DA was counteracted by the l µ N18TG2 cells (IC&! 19–100 M), as well as the binding of the CB" antagonist SR141716A. -
Fatty Acids: Essential…Therapeutic
Volume 3, No.2 May/June 2000 A CONCISE UPDATE OF IMPORTANT ISSUES CONCERNING NATURAL HEALTH INGREDIENTS Written and Edited By: Thomas G. Guilliams Ph.D. FATTY ACIDS: Essential...Therapeutic Few things have been as confusing to both patient and health care provider as the issue of fats and oils. Of all the essential nutrients required for optimal health, fatty acids have not only been forgotten they have been considered hazardous. Health has somehow been equated with “low-fat” or “fat-free” for so long, to suggest that fats could be essential or even therapeutic is to risk credibility. We hope to give a view of fats that is both balanced and scientific. This review will cover the basics of most fats that will be encountered in dietary or supplemental protocols. Recommendations to view essential fatty acids in a similar fashion as essential vitamins and minerals will be combined with therapeutic protocols for conditions ranging from cardiovascular disease, skin conditions, diabetes, nerve related disorders, retinal disorders and more. A complete restoration of health cannot be accomplished until there is a restoration of fatty acid nutritional information among health care professionals and their patients. Fats- What are they? Dietary fats come to us from a variety of sources, but primarily in the form of triglycerides. That is, three fatty acid molecules connected by a glycerol backbone (see fatty acid primer page 3 for diagram). These fatty acids are then used as energy by our cells or modified into phospholipids to be used as cell or organelle membranes. Some fatty acids are used in lipoprotein molecules to shuttle cholesterol and fats to and from cells, and fats may also be stored for later use. -
Relationship Between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients
Relationship between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients A thesis submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Master of Science in the Department of Nutrition of the College of Allied Health Sciences by Michael R. Ciresi B.S. The Ohio State University June 2008 Committee Chair: Grace Falciglia, Ph.D. Abstract Background. Crohn’s disease (CD) and ulcerative colitis (UC), collectively known as inflammatory bowel disease (IBD), are chronic illnesses that affect predominately the gastrointestinal tract. The pathogenesis and etiology remain unclear but the importance of environmental factors, in particular diet, is evidenced by the increased incidence rates of the recent decades that genetic inheritance cannot account for. In particular, the quantity of fatty acid consumption has been consistently linked with IBD risk. While several studies have investigated the connections between diet, etiology, signs and symptoms associated with IBD, very few have explored the relationship between disease state and specific fatty acid intake in the pediatric IBD population. Methods. In this cross-sectional study, 100 pediatric patients from Cincinnati Children’s Hospital and the Hospital for Sick Children in Toronto with diagnosed IBD (73 with Crohn’s disease (CD) and 27 with ulcerative colitis (UC)) were included. Three-day diet records were collected from the patients for the assessment of their dietary intake. The abbreviated Pediatric Crohn’s Disease Activity Index (PCDAI), the abbreviated Ulcerative Colitis Activity Index (PUCAI), and markers of inflammation (lipopolysaccharide binding protein (LBP) and S100A12) were used to assess disease severity. -
Experiment 7 Organic Synthesis: Microwave-Assisted Fischer
EXPERIMENT 7 ORGANIC SYNTHESIS: MICROWAVE-ASSISTED FISCHER ESTERIFICATION Materials Needed 1.0-2.0 mL of an alcohol to be chosen from the following: 3-methyl•1-butanol (isoamyl alcohol, isopentyl alcohol), 1-octanol (n-octyl alcohol), phenylmethanol (benzyl alcohol) 2.0 mL acetic acid 10 drops concentrated sulfuric acid 0.2 g silica beads saturated aqueous sodium chloride (sat NaCl(aq)) 10% aqueous sodium bicarbonate (NaHCO3(aq)) anhydrous sodium sulfate pellets (Na2SO4(s)) 10 mL diethyl ether 1 GlassChem™ pressure vessel and torque tool for tightening cap 1 very large test tube, several small test tubes, 1 screw-cap vial, Pasteur Pipettes Textbook Reading Assignment Smith, Chapter 13.6 INTRODUCTION A carboxylic acid and an alcohol react in the presence of an acid catalyst to form an ester and water as shown in equation 1. This reaction, termed Fischer esterification in honor of its discoverer, can be used to prepare a variety of esters. O H+(cat) O R C OH HOR' R C OR' H2O (1) carboxylic acid alcohol ester water side product The esterification reaction is reversible with an equilibrium constant that favors the products only slightly. Therefore, in order to get a decent yield of the ester product, an excess of one of the reactants is usually used to drive the equilibrium to the right (Le Chatelier's Principle). In addition, a drying agent, such as silica beads can be used to absorb the water side product as it is formed and again drive the equilibrium toward the products. However, this reaction is rather slow (even at elevated temperatures with the acid catalyst added); too slow to allow us to carry it out in a 2-hour lab period using standard heating methods. -
Since 1992 There Have Been Many Products Marketed As Cosmetics Designed to Exfoliate the Skin 1 2
SCCNFP/0370/00, final The Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (SCCNFP) has been requested to give an opinion on the safety of alpha-Hydroxy Acids in cosmetic products. The attached Position Paper of the SCCNFP has been prepared in this respect. The Commission services invite interested parties for their comments. Please send your comments before 15 September 2000 at the following e-mail address : [email protected] SCCNFP/0370/00, final The safety of alpha-Hydroxy acids ____________________________________________________________________________________________ THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS. POSITION PAPER CONCERNING THE SAFETY OF ALPHA-HYDROXY ACIDS Adopted by the SCCNFP during the 13th plenary meeting of 28 June 2000 2 SCCNFP/0370/00, final The safety of alpha-Hydroxy acids ____________________________________________________________________________________________ 1. Terms of reference The safety of α-hydroxy acids in cosmetic products has been questioned by some Member States with respect to their dermal tolerance. Hydroxy acids have a long history of use in dermatological preparations and recently have become important ingredients in cosmetics. Concerns on both the dermal and systemic safety of these materials has led to calls for their listing in Annex III (List of substances which cosmetic products must not contain except subject to restrictions and conditions laid down) to the Cosmetics Directive 76/768/EEC. 2. Position of the SCCNFP Definition of AHAs AHAs are carboxylic acids substituted with a hydroxyl group on the alpha carbon. The AHAs most commonly used in cosmetic products are glycolic acid and lactic acid.